Palo Alto, CA, United States of America

Aaron M Newman

This inventor holds 15 USPTO granted patents and 14 published patent applications and 8 EPO patents, primarily in Cellular Analysis. Top assignee: Leland Stanford Junior University. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aaron M Newman. Retrieved from https://idiyas.com/inventor/aaron-m-newman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.2

ph-index = 3

Forward Citations = 15(Granted Patents)


Location History:

  • Palo Alto, CA (US) (2019 - 2021)
  • Denver, CO (US) (2023)
  • San Mateo, CA (US) (2023 - 2024)

Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Circulating Nucleic Acids
Tumor Markers
Cell Subsets
Single Cell Analysis
Genetic Data
Mixed Cell Populations
Proportions Analysis
Cell Population
Methods
Systems
15 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Aaron M Newman

Introduction

Aaron M Newman is a prominent inventor based in Palo Alto, California. He has made significant contributions to the field of biotechnology, particularly in the area of cancer diagnostics and treatment. With a total of seven patents to his name, Newman is recognized for his innovative approaches to analyzing genetic alterations and tumor markers.

Latest Patents

Newman's latest patents include groundbreaking methods for the identification and use of circulating nucleic acid tumor markers. These methods provide a way to create a selector of mutated genomic regions, which can be used to analyze genetic alterations in cell-free nucleic acid samples. This technology allows for the measurement of tumor-derived nucleic acids in blood samples, enabling the monitoring of disease progression in patients. Additionally, these methods are applicable for cancer screening, diagnosis, prognosis, and therapy designation. Another notable patent involves systems and methods for analyzing mixed cell populations, which includes digital cytometry and digital analysis of biological samples. This innovation aids in evaluating diseases and predicting clinical outcomes of therapies.

Career Highlights

Aaron M Newman is affiliated with Leland Stanford Junior University, where he continues to advance research in his field. His work has garnered attention for its potential impact on cancer treatment and patient care. Newman's dedication to innovation is evident in his extensive research and development efforts.

Collaborations

Throughout his career, Newman has collaborated with esteemed colleagues, including Arash

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…